Solutions for Gluten Induced Disorders
AMYRA Biotech AG
AMYRA Biotech AG is a Swiss joint stock company founded by serial entrepreneurs in the life sciences sector.
How is AMYRA fighting celiac disease and gluten sensitivity?
AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. Both conditions are triggered by the ingestion of gluten in genetically predisposed people. Gluten is ubiquitously present in the Western diet and thus almost impossible to avoid.
AMY01 & AMY02
AMYRA‘s two lead product candidates are AMY01 for the treatment of celiac disease and AMY02 for the treatment of gluten sensitivity. Each product comprises of two proprietary, synergistically acting, recombinant enzymes that rapidly and entirely destroy the immunogenic structure of gluten-immunogenic peptides (toxic proline-rich peptides), when taken together with gluten-containing food – a phenomenon that has never been shown before. The enzymes are safe, highly effective and stable.
What does it mean for patients?
Celiac patients suffer from extremely discomforting acute symptoms and have a high risk of developing serious long-term complications, including cancer, osteoporosis, arthritis and others. Despite being the most common autoimmune disease worldwide, no effective treatment is available to date to address this vast unmet medical need. Strict, life-long avoidance of gluten is the only available treatment option but is very difficult to achieve in practice.
What does it mean for patients?
Celiac patients suffer from extremely discomforting acute symptoms and have a high risk of developing serious long-term complications, including cancer, osteoporosis, arthritis and others. Despite being the most common autoimmune disease worldwide, no effective treatment is available to date to address this vast unmet medical need. Strict, life-long avoidance of gluten is the only available treatment option but is very difficult to achieve in practice.
What makes AMYRA unique?
AYMRA’s products have the potential to establish a new standard of care and majorly impact the lives of affected people.
AMYRA’s Development Pipeline
Discovery
Lead Optimization
Pre-Clinical
Clinical
Indication
AMY01: Celiac Disease
AMY02: Gluten Sensitivity
AMY03: Diagnostic Tool
AMY04: Food Additive
AMYRA’s Development Pipeline
AMYRA’s Development Pipeline
AMY01: Celiac Disease
AMY02: Gluten Sensitivity
AMY03: Diagnostic Tool
AMY04: Food Additive
About Us
Company Management
Board of Directors
Scientific Advisory Board
Contact Us
This website is operated by
AMYRA Biotech AG
Malzgasse 9
CH – 4052 Basel
+41 61 515 07 70
UID CHE-321.956.288 MWST
ISIN-No. CH0359875991
Welcome to AMYRA Biotech AG. By using our website, you are accepting the following:
Copyright and Limitation of Liability
This website and its content are copyrighted by AMYRA Biotech AG. You may use, e.g. download or copy any content form this website for personal use only. Any other use of the content of this website is not permitted.
“Sand-Sailing” image © TZ SPO
“Team” image © alfa27 / Adobe Stock
“Woman Eating” © Martinan / Adobe Stock
“Basel Skyline” © bill_17 / Adobe Stock
This website is for information purposes only and does not contain medical advice. While we are diligently updating our website, we are not bound by the information published and do not guarantee the content to be accurate or up-to-date. AMYRA Biotech AG cannot be held liable for any damage that could arise out of or in connection with the use of this website. AMYRA Biotech AG is particularly not responsible for damage resulting from incorrect, incomplete or outdated information or the loss of data. In case we are linking to other websites, AMYRA Biotech AG is not responsible for such third-party websites. All such limitations are subject to the extent permissible under the applicable law.
Privacy and Personal Data
AMYRA Biotech AG respects your privacy. You can browse this website without providing us with personal data. We may collect, store and process your personal data if you contact us by email. We will use your personal data for administrative purposes and to inform you about our services and products. We will not provide third parties with your personal data for purposes other than those listed.
We use cookies on this website. Cookies are small text files which are downloaded onto your hard disk when you access this website. Cookies allow recognizing your preferences or past actions and assist you with navigation on the website. You may disable the cookies function in your web browser, if you do not want to allow cookies being stored on your computer. With cookies deactivated, not all features of this website may function properly.